US: +1 512 898-9222
SG: +65 3138-4148
China IVD Device Registration
IVD device registration and importation in China requires a Medical Device Registration Certificate (MDRC) issued by the National Medical Products Administration (NMPA), formerly known as the China Food and Drug Administration (CFDA). This document is technically owned by the foreign manufacturer, but is controlled by the Legal Agent listed on the certificate who is responsible for the registration application (To learn more about how to transfer a China Legal Agent, please visit our China Medical Device Registration page). Products must have home country approval prior to applying for registration in China.
Low Risk Class I IVD devices are subject to a filing process with applications submitted to the NMPA through the new eRPS system (link to blog). Administrative review and MDRC issuance takes about 4 weeks from application submission.
Medium Risk Class II and High Risk Class III IVD devices are subject to a registration process with applications and supporting documentation submitted to the NMPA. Product testing certificates issued from a (local) NMPA certified laboratory are a required element of the application. Local clinical test data is also required for all Class II and III IVD devices. Review and MDRC issuance can take 12 to 24 months.
Under new regulations, the NMPA will charge different application processing fees by device classification. The fees have yet to be determined and implemented. The MDRC is valid for 5 years from the date of issuance.
Contact Asia Actual for assistance with NMPA IVD device classification, regulatory costs and timeline and clinical data requirement exemption determination. Asia Actual is available to help navigate the complex medical device registration requirements and regulatory pathway for medical device and IVD distribution in China.
China Regulatory Support
US: +1 512 898-9222
Latest Market Updates
- China’s Green Pathway Registration for Innovative Medical DevicesMarch 16, 2021 - 9:11 pm
- NMPA to Pilot Program Allowing Hong Kong Approved Products to Be Sold in Mainland ChinaDecember 16, 2020 - 4:59 pm
- Sales Target Spotlight: China’s Boao Hope CityNovember 24, 2020 - 5:20 pm
- China Regulatory and Commercial UpdatesNovember 4, 2020 - 6:21 pm
- CHINA MEDICAL DEVICE AND IVD CLINICAL TRIAL EXEMPTION LISTSeptember 1, 2020 - 4:32 pm